Aquestive Therapeutics, Inc. (AQST)
Nasdaq: AQST · CIK 0001398733 · United States
Every official Aquestive Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AQST filings
Aquestive Therapeutics, Inc. documents
- Aquestive Therapeutics, Inc. 10-K 2026AQST 10-K 2026: annual report for fiscal 2026
- Aquestive Therapeutics, Inc. 10-K 2025AQST 10-K 2025: annual report for fiscal 2025
- Aquestive Therapeutics, Inc. 10-K 2024AQST 10-K 2024: annual report for fiscal 2024
- Aquestive Therapeutics, Inc. 10-K 2023AQST 10-K 2023: annual report for fiscal 2023
- Aquestive Therapeutics, Inc. 10-K 2022AQST 10-K 2022: annual report for fiscal 2022
- Aquestive Therapeutics, Inc. 10-Q 2026AQST 10-Q 2026: quarterly report for fiscal 2026
- Aquestive Therapeutics, Inc. 10-Q 2025AQST 10-Q 2025: quarterly report for fiscal 2025
- Aquestive Therapeutics, Inc. 10-Q 2024AQST 10-Q 2024: quarterly report for fiscal 2024
- Aquestive Therapeutics, Inc. 10-Q 2023AQST 10-Q 2023: quarterly report for fiscal 2023
- Aquestive Therapeutics, Inc. 10-Q 2022AQST 10-Q 2022: quarterly report for fiscal 2022
- Aquestive Therapeutics, Inc. 8-K 2026AQST 8-K 2026: current report for fiscal 2026
- Aquestive Therapeutics, Inc. 8-K 2025AQST 8-K 2025: current report for fiscal 2025
- Aquestive Therapeutics, Inc. 8-K 2024AQST 8-K 2024: current report for fiscal 2024
- Aquestive Therapeutics, Inc. 8-K 2023AQST 8-K 2023: current report for fiscal 2023
- Aquestive Therapeutics, Inc. 8-K 2022AQST 8-K 2022: current report for fiscal 2022
- Aquestive Therapeutics, Inc. DEF 14A 2026AQST DEF 14A 2026: proxy statement for fiscal 2026
- Aquestive Therapeutics, Inc. DEF 14A 2025AQST DEF 14A 2025: proxy statement for fiscal 2025
- Aquestive Therapeutics, Inc. DEF 14A 2024AQST DEF 14A 2024: proxy statement for fiscal 2024
- Aquestive Therapeutics, Inc. DEF 14A 2023AQST DEF 14A 2023: proxy statement for fiscal 2023
- Aquestive Therapeutics, Inc. DEF 14A 2022AQST DEF 14A 2022: proxy statement for fiscal 2022
- Aquestive Therapeutics, Inc. Form 4 2026AQST Form 4 2026: insider trading filing for fiscal 2026
- Aquestive Therapeutics, Inc. Form 4 2025AQST Form 4 2025: insider trading filing for fiscal 2025
- Aquestive Therapeutics, Inc. Form 4 2024AQST Form 4 2024: insider trading filing for fiscal 2024
- Aquestive Therapeutics, Inc. Form 4 2023AQST Form 4 2023: insider trading filing for fiscal 2023
- Aquestive Therapeutics, Inc. Form 4 2022AQST Form 4 2022: insider trading filing for fiscal 2022
- Aquestive Therapeutics, Inc. S-1 2026AQST S-1 2026: registration statement for fiscal 2026
- Aquestive Therapeutics, Inc. S-1 2025AQST S-1 2025: registration statement for fiscal 2025
- Aquestive Therapeutics, Inc. S-1 2024AQST S-1 2024: registration statement for fiscal 2024
- Aquestive Therapeutics, Inc. S-1 2023AQST S-1 2023: registration statement for fiscal 2023
- Aquestive Therapeutics, Inc. S-1 2022AQST S-1 2022: registration statement for fiscal 2022
- Aquestive Therapeutics, Inc. 13F 2026AQST 13F 2026: institutional holdings for fiscal 2026
- Aquestive Therapeutics, Inc. 13F 2025AQST 13F 2025: institutional holdings for fiscal 2025
- Aquestive Therapeutics, Inc. 13F 2024AQST 13F 2024: institutional holdings for fiscal 2024
- Aquestive Therapeutics, Inc. 13F 2023AQST 13F 2023: institutional holdings for fiscal 2023
- Aquestive Therapeutics, Inc. 13F 2022AQST 13F 2022: institutional holdings for fiscal 2022
More companies